The DeepSense Team

Get to Know Us

th[8].jpg

Johan Brag

Chief Executive Officer

victoria.jpg

Victoria Vertesi

Chief Operating Officer

th.jpg

Shiming Li

Chief Scientific Officer

th[3].jpg

Brad Higgins

Chairman

Jasmina-Jankicevic.jpg

Jasmina Jankicevic

Chief Medical Officer

If you want to learn more about our amazing team members, get in touch.

 

About Us

A Revolution in Inflammation Drug Development

By combining the latest advances in biotechnology, organic chemistry and artificial intelligence we strive to find novel therapeutics which can enhance our innate immune system to better fight off diseases.  

A new opportunity for researchers and patients alike is drugs that target the innate immune system – our body’s first line of defense and the primary instigator of inflammation. The innate immune response relies on pattern-recognition receptors (PRRs) to detect pathogenic substances that may enter our bodies or form during tissue stress. “Inflammasomes” are newly identified PRRs that control the activation and release of powerful inflammation mediators. They are members of the IL-1beta family of cytokines and thus play an integral role in innate immunity.


Scientist